Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.180
-0.180 (-13.24%)
Jun 3, 2026, 4:00 PM EDT - Market closed
Tiziana Life Sciences Employees
Tiziana Life Sciences had 9 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
9
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,047,889
Market Cap
152.58M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 9 | 0 | - |
| Dec 31, 2023 | 9 | 0 | - |
| Dec 31, 2022 | 9 | -5 | -35.71% |
| Dec 31, 2021 | 14 | 3 | 27.27% |
| Dec 31, 2020 | 11 | 3 | 37.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Innate Pharma | 164 |
| MediWound | 121 |
| Precision BioSciences | 66 |
| Acumen Pharmaceuticals | 61 |
| Korro Bio | 49 |
| OnKure Therapeutics | 45 |
| Milestone Pharmaceuticals | 38 |
| Equillium | 15 |
TLSA News
- 7 days ago - Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference in New York - GlobeNewsWire
- 13 days ago - Tiziana fully enrolls Phase 2 placebo-controlled MS trial - TheFly
- 13 days ago - Tiziana Fully Enrolls its Phase 2 Placebo Controlled Multiple Sclerosis Trial - GlobeNewsWire
- 16 days ago - Tiziana Life Sciences announces updated intranasal foralumab data - TheFly
- 16 days ago - Tiziana Announces New Positive Clinical Data for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis - GlobeNewsWire
- 20 days ago - Tiziana Phase 2 trial for foralumab shows reduced brain inflammation - TheFly
- 21 days ago - Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab - GlobeNewsWire
- 7 weeks ago - Tiziana Life announces publication of preclinical data in bioRxiv preprint - TheFly